The estimated Net Worth of Chemical Co /De/ Dow is at least $10.1 Billion dollars as of 30 August 2017. Chemical Dow owns over 4,758 units of Pfenex stock worth over $10,020,540,359 and over the last 10 years Chemical sold PFNX stock worth over $39,573,635.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Sign up
Chemical Dow PFNX stock SEC Form 4 insiders trading
Chemical has made over 16 trades of the Pfenex stock since 2015, according to the Form 4 filled with the SEC. Most recently Chemical bought 4,758 units of PFNX stock worth $33,258 on 30 August 2017.
The largest trade Chemical's ever made was selling 2,232,233 units of Pfenex stock on 29 April 2015 worth over $32,523,635. On average, Chemical trades about 169,035 units every 47 days since 2014. As of 30 August 2017 Chemical still owns at least 17,710,393 units of Pfenex stock.
You can see the complete history of Chemical Dow stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Chemical Dow's mailing address?
Chemical's mailing address filed with the SEC is 2030 DOW CENTER, , MIDLAND, MI, 48674.
Insiders trading at Pfenex
Over the last 10 years, insiders at Pfenex have traded over $99,496,796 worth of Pfenex stock and bought 36,000 units worth $174,640 . The most active insiders traders include Chemical Co /De/ Dow, James C Gale, and Healthcare Partners Accredi.... On average, Pfenex executives and independent directors trade stock every 46 days with the average trade being worth of $90,240,574. The most recent stock trade was executed by Asset Management Lpweiss An... on 29 September 2020, trading 100,000 units of PFNX stock currently worth $1,274,000.
What does Pfenex do?
Pfenex, Inc. is a development and licensing Biotechnology Company, which focuses on leveraging its Pfenex Expression Technology platform for developing and improving protein therapies. Its products include PF708, PF743, PF745, CRM197, PF810, PF753 and PFXX. The company was founded on November 19, 2009 and is headquartered in San Diego, CA.
What does Pfenex's logo look like?
Complete history of Chemical Dow stock trades at AgroFresh Solutions Inc and Pfenex
Pfenex executives and stock owners
Pfenex executives and other stock owners filed with the SEC include:
-
Shawn Scranton,
Chief Operating Officer -
Susan A. Knudson,
Chief Financial Officer -
Evert B. Schimmelpennink,
See Remarks -
Patricia Lady,
Chief Accounting Officer -
Jason Grenfell Gardner,
Director -
Martin Brenner,
Chief Scientific Officer -
Magda Marquet,
Director -
Phillip M Schneider,
Director -
Sigurdur O Olafsson,
Director -
Hubert C Chen,
Chief Medical Officer -
John Mack Taylor,
Director -
Patrick K. Lucy,
Chief Business Officer -
Robin Campbell,
Director -
Lorianne Masuoka,
Director -
Dennis M Fenton,
Director -
William R Rohn,
Director -
Henry W. Jr. Talbot,
VP of Research & Operations -
Healthcare Partners Accredi...,
10% owner -
Bertrand C. Liang,
Chief Executive Officer -
Steven S. Sr. Sandoval,
Chief Manufacturing Officer -
Paul A. Wagner,
Chief Financial Officer -
Chemical Co /De/ Dow,
10% owner -
Healthcare Partners Accredi...,
-
James C Gale,
Director -
Asset Management Lpweiss An...,
-
Management, Llc Newtyn,
10% owner